These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 37141667

  • 1. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F.
    Nakajima R, Deguchi R, Komori H, Zhao L, Zhou Y, Shirasawa M, Angelina A, Goto Y, Tohjo F, Nakahashi K, Nakata K, Iwanaga R, Bradford AP, Araki K, Warita T, Ohtani K.
    Biochem Biophys Res Commun; 2023 Jun 30; 663():154-162. PubMed ID: 37141667
    [Abstract] [Full Text] [Related]

  • 2. Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes.
    Komori H, Goto Y, Kurayoshi K, Ozono E, Iwanaga R, Bradford AP, Araki K, Ohtani K.
    Sci Rep; 2018 May 31; 8(1):8438. PubMed ID: 29855511
    [Abstract] [Full Text] [Related]

  • 3. Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool.
    Nakajima R, Zhao L, Zhou Y, Shirasawa M, Uchida A, Murakawa H, Fikriyanti M, Iwanaga R, Bradford AP, Araki K, Warita T, Ohtani K.
    Genes (Basel); 2023 Feb 02; 14(2):. PubMed ID: 36833320
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts.
    Kitamura H, Ozono E, Iwanaga R, Bradford AP, Okuno J, Shimizu E, Kurayoshi K, Kugawa K, Toh H, Ohtani K.
    Genes Cells; 2015 Sep 02; 20(9):739-57. PubMed ID: 26201719
    [Abstract] [Full Text] [Related]

  • 8. Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.
    Kurayoshi K, Ozono E, Iwanaga R, Bradford AP, Komori H, Ohtani K.
    Biochem Biophys Res Commun; 2014 Jul 18; 450(1):240-6. PubMed ID: 24893334
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, Kim HT, Brown PH.
    Oncogene; 2008 Jan 10; 27(3):366-77. PubMed ID: 17637753
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. COMMD9 promotes TFDP1/E2F1 transcriptional activity via interaction with TFDP1 in non-small cell lung cancer.
    Zhan W, Wang W, Han T, Xie C, Zhang T, Gan M, Wang JB.
    Cell Signal; 2017 Jan 10; 30():59-66. PubMed ID: 27871936
    [Abstract] [Full Text] [Related]

  • 17. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
    Jones SJ, Dicker AJ, Dahler AL, Saunders NA.
    J Invest Dermatol; 1997 Aug 10; 109(2):187-93. PubMed ID: 9242506
    [Abstract] [Full Text] [Related]

  • 18. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM, Gall AL, Zheng N, Pavletich NP.
    Cell; 2005 Dec 16; 123(6):1093-106. PubMed ID: 16360038
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regulation of the Arf/p53 tumor surveillance network by E2F.
    Iaquinta PJ, Aslanian A, Lees JA.
    Cold Spring Harb Symp Quant Biol; 2005 Dec 16; 70():309-16. PubMed ID: 16869767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.